Litcius/Paper detail

Lipid moieties of Mycoplasma pneumoniae lipoproteins are the causative factor of vaccine-enhanced disease

Arlind B. Mara, Tyler D. Gavitt, E. R. Tulman, Steven J. Geary, Steven M. Szczepanek

2020npj Vaccines23 citationsDOIOpen Access PDF

Abstract

Abstract Vaccine-enhanced disease (VED) occurs as a result of vaccination followed by infection with virulent Mycoplasma pneumoniae . To date VED has prevented development of an efficacious vaccine against this significant human respiratory pathogen. Herein we report that vaccination of BALB/c mice with M. pneumoniae lipid-associated membrane proteins (LAMPs) induces lung lesions consistent with exacerbated disease following challenge, without reducing bacterial loads. Removal of lipid moieties from LAMPs prior to vaccination eliminates VED and reduces bacterial loads after infection. Collectively, these data indicate that lipid moieties of lipoproteins are the causative factors of M. pneumoniae VED.

Topics & Concepts

Mycoplasma pneumoniaeVaccinationPathogenMicrobiologyMycoplasmaVirulenceMycoplasmataceaeVirulence factorImmunologyVirologyMollicutesMedicineBiologyPneumoniaGeneBiochemistryInternal medicinePneumonia and Respiratory InfectionsMicrobial infections and disease researchInfluenza Virus Research Studies
Lipid moieties of Mycoplasma pneumoniae lipoproteins are the causative factor of vaccine-enhanced disease | Litcius